These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

80 related items for PubMed ID: 5337927

  • 1. [Induced tolerance to antitumor effect of bacterial polysaccharides].
    Navashin SM, Fomina IP, Terent'eva TG.
    Antibiotiki; 1965 Nov; 10(11):1011-6. PubMed ID: 5337927
    [No Abstract] [Full Text] [Related]

  • 2. [Experimental-clinical study of combined use of antibiotics and prodigiozan].
    Vaĭsberg GE, Taranenko LA, Zhukovskaia LN.
    Antibiotiki; 1967 Nov; 12(11):1040-3. PubMed ID: 4298568
    [No Abstract] [Full Text] [Related]

  • 3. [Effect of some bacterial polysaccharides of phagocytic activity of leukocytes].
    Vaĭsberg GE, Likina TN.
    Antibiotiki; 1969 Dec; 14(12):1088-92. PubMed ID: 4905937
    [No Abstract] [Full Text] [Related]

  • 4. [Effect of post-irradiation use of prodigiozan on survival and blood system of irradiated animals].
    Ermol'eva ZV, Vaĭsberg GE, Dikovenko EA, Elistratova ZhV.
    Antibiotiki; 1972 Jun; 17(6):517-22. PubMed ID: 4558228
    [No Abstract] [Full Text] [Related]

  • 5. [Prodigiozan effect of the distribution of antibiotics in blood and organs of rats].
    Kalinina NA, Geĭtman IIa, Balyn IR, Ermol'eva ZV.
    Antibiotiki; 1972 Jun; 17(6):532-5. PubMed ID: 4625691
    [No Abstract] [Full Text] [Related]

  • 6. [Prodigiozan stimulation of the defense reactions of the organism sustaining a severe toxicoinfectious process].
    Givental' NI.
    Antibiotiki; 1970 Apr; 15(4):335-40. PubMed ID: 4923029
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Use of prodigiozan in severe leukopenia, caused by treatment of echinococcosis and cenurosis by compound benzotef].
    Mad'iarov SD, Sadykov VM, Kantserova VA, Makhmudov SB.
    Antibiotiki; 1969 Oct; 14(10):941-3. PubMed ID: 4901556
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Journal of the National Cancer Institute, Vol. 29, 1962: Action of bacterial polysaccharide on tumors. II. Damage of sarcoma 37 by serum of mice treated with Serratia marcescens polysaccharide, and induced tolerance.
    O'Malley WE, Achinstein B, Shear MJ.
    Nutr Rev; 1988 Nov; 46(11):389-91. PubMed ID: 3070444
    [No Abstract] [Full Text] [Related]

  • 14. [Stimulation of antibody formation in animals under the effect of the bacterial lipopolysaccharide--prodigiozan].
    Afanas'eva TI, Vaĭsberg GE.
    Zh Mikrobiol Epidemiol Immunobiol; 1968 Nov; 45(11):48-52. PubMed ID: 4186105
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Nonspecific stimulation of the body's natural resistance to infection with prodigiozan].
    Bukharin OV.
    Zh Mikrobiol Epidemiol Immunobiol; 1966 Sep; 43(9):54-8. PubMed ID: 4981249
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Experiences with the use of Prodigiozan in therapy of prostatitis].
    Scuratovich AA, Potapnev FV, Levochkin AM.
    Antibiotiki; 1973 Oct; 18(10):938-40. PubMed ID: 4587064
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.